These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5105870)

  • 21. Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.
    Bourne HR; Bunney WE; Colburn RW; Davis JM; Davis JN; Shaw DM; Coppen AJ
    Lancet; 1968 Oct; 2(7572):805-8. PubMed ID: 4175606
    [No Abstract]   [Full Text] [Related]  

  • 22. (+)-Amphetamine oral 'drug taking behavior' in naive and tolerant rats.
    Jänicke UA; Coper H
    Drug Alcohol Depend; 1984 Mar; 13(2):177-89. PubMed ID: 6539195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific noradrenergic neurones destroyed by 6-hydroxydopamine injection into newborn rats.
    Taylor KM; Clark DW; Laverty R; Phelan EL
    Nat New Biol; 1972 Oct; 239(95):247-8. PubMed ID: 4507808
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of stimulants of the central nervous system on the motor activity of rats and the noradrenaline content in the brain stem].
    Sharov PA
    Farmakol Toksikol; 1967; 30(5):535-9. PubMed ID: 4386332
    [No Abstract]   [Full Text] [Related]  

  • 25. A rapid method for the simultaneous determination of noradrenaline, dopamine and 5HT in small samples of brain tissue.
    Metcalf G
    Anal Biochem; 1974 Jan; 57(1):316-20. PubMed ID: 4817509
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of 6-hydroxydopamine on putative transmitter substances in the central nervous system.
    Jacks BR; de Champlain J; Cordeau JP
    Eur J Pharmacol; 1972 May; 18(3):353-60. PubMed ID: 5035623
    [No Abstract]   [Full Text] [Related]  

  • 27. Abnormalities in monoamine levels in the central nervous system of the genetically epilepsy-prone rat.
    Jobe PC; Laird HE; Ko KH; Ray T; Dailey JW
    Epilepsia; 1982 Aug; 23(4):359-66. PubMed ID: 6284498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central nervous system effects of fenfluramine hydrochloride.
    Ziance RJ; Sipes IG; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1972 Jan; 180(1):110-7. PubMed ID: 5062254
    [No Abstract]   [Full Text] [Related]  

  • 29. Central action of phentolamine administered intraventricularly in the rat.
    Kleinrok Z; Zebrowska-Lupina I
    Psychopharmacologia; 1971; 20(4):348-54. PubMed ID: 5109250
    [No Abstract]   [Full Text] [Related]  

  • 30. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS; McAllister C; Geyer MA
    Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
    [No Abstract]   [Full Text] [Related]  

  • 31. The induction of ethanol dependence and the ethanol withdrawal syndrome: the effects of pyrazole.
    Littleton JM; Griffiths PJ; Ortiz A
    J Pharm Pharmacol; 1974 Feb; 26(2):81-91. PubMed ID: 4150837
    [No Abstract]   [Full Text] [Related]  

  • 32. Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
    Arnt J; Overø KF; Hyttel J; Olsen R
    Psychopharmacology (Berl); 1984; 84(4):457-65. PubMed ID: 6441945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of three dihydroxylated derivatives of tryptamine on the behavior and on brain amine content in mice.
    Massotti M; Scotti de Carolis A; Longo VG
    Pharmacol Biochem Behav; 1974; 2(6):769-76. PubMed ID: 4549398
    [No Abstract]   [Full Text] [Related]  

  • 34. The central action of intraventricularly (ivc) administered propranolol and phentolamine in rat.
    Kleinrok Z; Ksiazek A; Przesmycki K; Kolasa K
    Pol J Pharmacol Pharm; 1975; 27(4):405-12. PubMed ID: 1166021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An autoradiographic study of the distribution of C14-norepinephrine in the brain of the rat.
    Reivich M; Glowinski J
    Brain; 1967 Sep; 90(3):633-46. PubMed ID: 6058145
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of 6-hydroxydopamine on CNS catecholamines, spontaneous motor activity and amphetamine induced hyperactivity in rats.
    Evetts KD; Uretsky NJ; Iversen LL; Iversen SD
    Nature; 1970 Mar; 225(5236):961-2. PubMed ID: 5415137
    [No Abstract]   [Full Text] [Related]  

  • 37. Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.
    Archer T; Fredriksson A; Jonsson G; Lewander T; Mohammed AK; Ross SB; Söderberg U
    Psychopharmacology (Berl); 1986; 88(2):141-6. PubMed ID: 3081924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyrosine hydroxylase inhibitors.
    Moore KE; Dominic JA
    Fed Proc; 1971; 30(3):859-70. PubMed ID: 4324974
    [No Abstract]   [Full Text] [Related]  

  • 39. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 40. Alterations in physiologic functions and in brain monoamine content in streptozocin-diabetic rats.
    Chu PC; Lin MT; Shian LR; Leu SY
    Diabetes; 1986 Apr; 35(4):481-5. PubMed ID: 3514326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.